A5018867761- Infant Nutrition and Health
- Neonatal Respiratory Health Research
- Breastfeeding Practices and Influences
- Infant Development and Preterm Care
- Fatty Acid Research and Health
- Child Nutrition and Feeding Issues
- Maternal and Perinatal Health Interventions
- Birth, Development, and Health
- Neuroscience of respiration and sleep
- Pediatric Pain Management Techniques
- Clinical Nutrition and Gastroenterology
- Neonatal and fetal brain pathology
- Complementary and Alternative Medicine Studies
- Maternal Mental Health During Pregnancy and Postpartum
- Congenital Diaphragmatic Hernia Studies
- Child Nutrition and Water Access
- Metabolism and Genetic Disorders
- Gestational Diabetes Research and Management
- Pain Management and Placebo Effect
- Intestinal Malrotation and Obstruction Disorders
- Pediatric health and respiratory diseases
- Asthma and respiratory diseases
- Anesthesia and Neurotoxicity Research
- Prenatal Substance Exposure Effects
- Infant Health and Development
The University of Adelaide
2015-2024
South Australian Health and Medical Research Institute
2015-2024
Women's & Children's Health Research Institute
2008-2018
Women's and Children's Hospital
2006-2018
Perinatal Institute
2002-2018
Women's and Children's Health Network
2010-2017
Flinders Medical Centre
2006-2015
Irish Hospice Foundation
2015
University of Michigan–Ann Arbor
2015
Boston Children's Hospital
2012
Uncertainty exists about the benefit of dietary docosahexaenoic acid (DHA) on neurodevelopment preterm infants.To determine effect meeting estimated DHA requirement infants at 18 months' corrected age.Randomized, double-blind controlled trial enrolling born less than 33 weeks' gestation from April 2001 to October 2005 5 Australian tertiary hospitals, with follow-up months.High-DHA (approximately 1% total fatty acids) enteral feeds compared standard 0.3% day 2 4 life until term age.Bayley...
OBJECTIVE: To identify sensitive periods of postnatal growth for preterm infants relative to neurodevelopment at 18 months' corrected age. PATIENTS AND METHODS: We studied 613 born <33 weeks' gestation who participated in the DHA Improvement Neurodevelopmental Outcome trial. calculated linear slopes weight, length, BMI, and head circumference from 1 week age term (40 postmenstrual age), 4 months, 12 we estimated their associations with Bayley Scales Infant Development, 2nd Edition,...
Studies in animals and humans have suggested that docosahexaenoic acid (DHA), an n-3 long-chain polyunsaturated fatty acid, might reduce the risk of bronchopulmonary dysplasia, but appropriately designed trials are lacking.We randomly assigned 1273 infants born before 29 weeks gestation (stratified according to sex, gestational age [<27 or 27 <29 weeks], center) within 3 days after their first enteral feeding receive either emulsion providing DHA at a dose 60 mg per kilogram body weight day...
Docosahexaenoic acid (DHA) has been associated with downregulation of inflammatory responses.To report the effect DHA supplementation on long-term atopic and respiratory outcomes in preterm infants.This study is a multicenter, randomized controlled trial comparing for infants <33 weeks' gestation who consumed expressed breast milk from mothers taking either tuna oil (high-DHA diet) or soy (standard-DHA) capsules. Data collected included incidence bronchopulmonary dysplasia (BPD) parental...
To determine if improvements in cognitive outcome detected at 18 months' corrected age (CA) infants born <33 weeks' gestation receiving a high-docosahexaenoic acid (DHA) compared with standard-DHA diet were sustained early childhood.Follow-up of multicentre randomised controlled trial. Randomisation was stratified for sex, birth weight (<1250 vs ≥1250 g) and hospital.Five Australian tertiary hospitals from 2008 to 2013.626 the 657 participants between 2001 2005 eligible participate.High-DHA...
Maternal milk feeding may have unique long-term neurodevelopmental benefits in very preterm infants.To examine the extent to which maternal after birth is associated with cognitive, academic, and behavioral outcomes at school age.This prospective cohort study assessed 586 infants born less than 33 weeks' gestation 5 Australian perinatal centers enrolled Docosahexaenoic Acid for Improvement of Neurodevelopmental Outcomes (January 1, 2001, December 31, 2005) who were evaluated a corrected age...
<h3>Abstract</h3> <b>Objective</b> To determine the effect of artificial teats (bottle and dummy) cups on breast feeding in preterm infants. <b>Design</b> Randomised controlled trial. <b>Setting</b> Two large tertiary hospitals, 54 peripheral hospitals. <b>Participants</b> 319 infants (born at 23-33 weeks9 gestation) randomly assigned to one four groups: cup/no dummy (n = 89), cup/dummy 72), bottle/no 73), bottle/dummy 85). Women with singleton or twin < 34 gestation who wanted breastfeed...
Docosahexaenoic acid (DHA) is a component of neural tissue. Because its accretion into the brain greatest during final trimester pregnancy, infants born before 29 weeks' gestation do not receive normal supply DHA. The effect this deficiency on subsequent cognitive development well understood.